Two drugs, eszopiclone and lemborexant – both not currently licenced for the treatment of insomnia in the UK – were shown to perform better than others, both in the acute and long-term treatment of insomnia in adults, according to a new Oxford study exploring the pharmacological management of insomnia. This new study, published in The…
News
Involving diverse communities in research
On 21st of June 2022, around 30 Oxford researchers and 12 public contributors came together at Oxford’s Old Fire Station to discuss ways of involving people from diverse communities in health research. Health researchers want to engage with people from diverse communities so that their research is more relevant to all of society. People who…
Building and sustaining capacity of our Young People’s Advisory Group
The second year of the covid pandemic proved to be another challenging year for everyone on many levels. On the bright side, we’ve powered through and ‘done’ a lot. We have continued exploring what meaningful and sustainable involvement entails across a breadth of opportunities and now is a good time to reflect on how these…
Breakthrough success in provision of automated psychological therapy using virtual reality (VR)
The value of involving communities in research – event highlights
The NIHR Oxford and Oxford Health Biomedical Research Centres (BRCs), together with the Diversity in Research Advisory group, have held a networking and learning event focused on the importance of diversity in research on the 22nd March 2022. The event took place at the Blavatnik School of Government in Oxford and was attended by 60…
New funding for Oxford Health Clinical Research Facility
The Oxford cognitive health Clinical Research Facility (CH CRF) has been awarded more than £4 million over the next five years by the National Institute for Health Research (NIHR). The CH CRF is one of 28 facilities across England to benefit from nearly £161 million that has been awarded to expand early phase clinical research delivery in NHS hospitals.
